Comprehensive Nursing Guide to Rapid-Acting Insulin, Cardiac Glycosides, and Beta-Blockers

Medication Administration Best Practices and the Eleven Rights

Medication administration requires a rigorous adherence to safety protocols to ensure best outcomes. The primary goal is encapsulated by delivering the right patient, right medication, right dose, right time, and right care. A central pillar of this process is the verification of the eleven rights of medication administration. These rights include verifying the Right Person through the use of at least $2$ identifiers and checking the Right Medication by inspecting the label. The Right Dose must be confirmed via accurate measurement and calculation. The Right Route and Right Form (such as tablet, capsule, or solution) must be strictly followed as prescribed.

Documentation is the sixth right, requiring an immediate record of the medication given. Patients also hold the Right to Refuse, which must be respected by healthcare providers. Timeliness is critical, ensuring the drug is given at the Right Time based on the clinical schedule. Before administration, the Right Expiry must be checked to ensure the drug is still valid. The Right Reason involves clinical knowledge of the specific indication for the drug. Finally, the Right Response/Assessment requires evaluating both the therapeutic effects and any potential side effects following administration. Safe medication practice is a continuous cycle of assessment, education, advocacy, documentation, monitoring, and reassessment.

Insulin Aspart (NovoRapid)

NovoRapid is a rapid-acting insulin analog and antidiabetic agent used in the management of diabetes mellitus and for maintaining glycemic control in both type $1$ and type $2$ patients. It is characterized by its quick onset, necessitating administration exactly $5-10\,minutes$ before meals. The usual dosage range is $0.01-0.2\,units/kg$ via subcutaneous injection (SC) before meals. While total daily doses are individualized to the patient's needs, the maximum dose per single administration is typically capped at $0.2\,units/kg$.

Contraindications for NovoRapid include known hypersensitivity to insulin aspart or current states of hypoglycemia. Precautions should be taken in patients with renal or hepatic impairment, as well as elderly or debilitated individuals who are at a higher risk for hypoglycemia. Adverse effects frequently encountered include weight gain, lipodystrophy at the injection site, and allergic reactions, with hypoglycemia being the most common. Certain drugs may increase the hypoglycemic effects of insulin, specifically alcohol, beta-blockers, ACE inhibitors, salicylates, and sulfonylureas.

Nursing considerations for NovoRapid involve checking blood glucose levels immediately before administration and rotating injection sites to prevent lipodystrophy. Effectiveness is monitored by achieving target blood glucose ranges, such as a Fasting Blood Sugar (FBS) of $80-130\,mg/dL$. The acronym "RAPID ACT" can be used to remember the key points: Rapid acting ($5-10\,min$ before meals), Action is lowering blood glucose, Pen injection SC, Insulin analog, and Diabetes management.

Digoxin (Cardiac Glycoside)

Digoxin is a positive inotropic agent and cardiac glycoside used to manage heart failure by improving symptoms and exercise tolerance, and to control the ventricular rate in atrial fibrillation or flutter. The drug is usually administered once daily at the same time each day. The usual dose ranges from $0.125-0.25\,mg$ orally (PO) or intravenously (IV) daily. While doses are individualized, the maintenance dose is usually $\le 0.25\,mg/day$, with a total daily maximum between $1.5\,mg$ and $2\,mg/day$.

Contraindications include hypersensitivity, ventricular fibrillation, and Wolff-Parkinson-White syndrome. Precautions are necessary for patients with renal impairment, which may require dose adjustments, and those with electrolyte imbalances like hypokalemia ($\downarrow K^+$), hypomagnesemia ($\downarrow Mg^{2+}$), or hypercalcemia ($\uparrow Ca^{2+}$). The elderly are also at increased risk for toxicity. Adverse effects include bradycardia, heart block, arrhythmias, confusion, weakness, and gastrointestinal issues such as nausea, vomiting, or anorexia. A hallmark sign of toxicity is visual disturbance, specifically blurred or yellow-tinged vision.

Digoxin levels and toxicity risk are increased by amiodarone, verapamil, quinidine, macrolide antibiotics, and azole antifungals. Conversely, levels are decreased by rifampin, phenytoin, and St. John's wort. Crucially, low potassium levels ($K^+$) significantly increase the risk of digoxin toxicity. Nursing care includes checking the apical pulse for $1$ full minute prior to administration; the dose must be held and the provider notified if the adult heart rate is $< 60\,bpm$. The therapeutic serum level for digoxin is $0.5-2.0\,ng/mL$.

The "DIG TOXIC" acronym summarizes these points: Digoxin once daily, Increase $K^+$ is good (low $K^+$ is bad), Green/Yellow vision indicates toxicity, Toxic if level is too high, Observe pulse (hold if $< 60$), Excreted by the kidney, Interacts with many drugs, and Cardiac effects like increased contractility.

Atenolol (Beta-1 Selective Blocker)

Atenolol is a selective beta-adrenergic blocker used as an antihypertensive and antianginal agent. It is indicated for hypertension, angina pectoris, and rate control in supraventricular arrhythmias. The standard dosage is $25-100\,mg$ PO once daily, with a maximum dose of $100\,mg/day$. It can be taken with or without food. Contraindications include hypersensitivity, bradycardia, second or third-degree heart block, uncompensated heart failure, cardiogenic shock, and respiratory conditions like asthma or COPD.

Precautions must be exercised in patients with peripheral vascular disease and diabetes mellitus, as atenolol may mask the physiological signs of hypoglycemia (such as tachycardia). Common adverse effects include bradycardia, hypotension, fatigue, dizziness, and cold extremities. Drug interactions include additive effects when combined with other antihypertensives, calcium channel blockers, or antiarrhythmics. It may also increase the hypoglycemic effects of antidiabetic agents.

Nursing considerations for atenolol involve checking the blood pressure and apical pulse before administration. The medication should be held if the heart rate is $< 60\,bpm$ or the systolic blood pressure is $\le 90\,mmHg$. A critical safety warning is to never stop the medication abruptly; it must be tapered as ordered to avoid rebound hypertension. Effectiveness is measured by reduced blood pressure and heart rate within the target range and relief of angina symptoms. The acronym "A-TEN-O-LOL" stands for: Antianginal, Treats high BP, Observe HR and BP, and Low pulse indicates a need to hold, while emphasizing the rule to never stop suddenly.

Clinical Monitoring and Vital Sign Parameters

Nurses must be vigilant in monitoring vital signs and recognizing signs of drug toxicity or adverse reactions. Adult hold parameters are defined as a Heart Rate ($HR$) $< 60\,bpm$, Systolic Blood Pressure ($SBP$) $< 90\,mmHg$, Respiratory Rate ($RR$) $< 12/min$, and Oxygen Saturation ($O_2\,sat$) $< 90\%$.

Signs of hypoglycemia include shakiness, sweating, hunger, dizziness, and irritability or confusion. Signs of digoxin toxicity specifically include nausea, vomiting, yellow or blurred vision, bradycardia, arrhythmias, and confusion. Patients on digoxin are encouraged to eat potassium-rich foods to mitigate toxicity risks, including bananas, oranges, potatoes, spinach, beans, and avocados.

Patient education is a vital component of nursing care. Patients should be taught to take medications exactly as prescribed and should be cautioned never to stop without provider advice. They must be instructed to report symptoms such as dizziness, fainting, palpitations, unusual bruising, or any signs of low blood sugar immediately.